A preliminary estimate, and a request for better ones.
Summary
I believe the standard literature estimates for the number of DALYs attributable to a case of stunting are too low, largely because they don’t account for the long term effects. This means that childhood nutritional interventions that reduce the prevalence of stunting may be substantially more cost-effective than previously believed.
Epistemic status
Exploratory and back-o...
I’ve been feeling pretty shaken since the METR report about the Hugging Face incident came out last week. Over the weekend, I wrote up some thoughts on how lonely the AI situation sometimes feels to me. It’s more personal than what I’d usually share publicly, but I thought I’d post it here in case it resonates with anyone else.
I’m very grateful to the man...
TL;DR: Kairos has raised $50 million from Coefficient Giving for two years of funding, one of the largest commitments they’ve made towards AI safety fieldbuilding to date. We’re using this to make an ambitious push for growing Kairos, broadening our portfolio of talent infrastructure projects and incubating new organizations. We’ve doubled in size in the last six mon...
[Related to: Logarithmic Scales of Pleasure and Pain; Anti-Tolerance Drugs]
Millions of people suffering from benzo/gabapentin/phenibut/alcohol withdrawal across the world thinking that tapering is the only solution, while it seems like people in Italy and Japan already figured out how to reverse tolerance without side-effects within a week? It's called Flumazenil and it's a GABAa antagonist, which when taken in microdoses can up-regulate GABA receptors (hear me out: up-regulation and other tolerance mechanisms are *not* proportional to subjective effect size - this insight makes all the difference).
See the wikipedia entry on it:
See also a video I made about why our common-sense view of how drug tolerance works gets in the way of actually solving this crisis.